Preliminary Safety and Anti-Tumor Activity of XmAb13676, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
暂无分享,去创建一个
G. Salles | R. Bouabdallah | A. Chanan-Khan | J. Pagel | D. Liebowitz | T. Phillips | W. Wierda | V. Ribrag | F. Peyrade | Sheeba K. Thomas | G. Cartron | J. Michot | M. Saville | E. Reid | K. Patel | Chelsea M. Johnson | T. Ly